nylidrin has been researched along with Diabetic Angiopathies in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karpman, HL | 1 |
| Okun, R | 1 |
1 trial available for nylidrin and Diabetic Angiopathies
| Article | Year |
|---|---|
The effect of vasodilating drugs in peripheral vascular disease.
Topics: Aged; Arteriosclerosis Obliterans; Cardiac Output; Clinical Trials as Topic; Diabetes Mellitus; Diab | 1972 |